American Journal of Kidney Diseases
Volume 43, Issue 5 , Pages 763-771 , May 2004

Restless legs syndrome in patients on dialysis

  • David Kavanagh, MRCP(UK)

      Affiliations

    • Department of Nephrology, Institute of Human Genetics, International Centre for Life, Newcastle-upon-Tyne, England, UK
    • ,
  • Samira Siddiqui, MRCP(UK)

      Affiliations

    • Renal Unit, Glasgow Royal Infirmary, Glasgow, Scotland, UK
    • ,
  • Colin C Geddes (FRCP(Glasgow))

      Affiliations

    • Renal Unit, Western Infirmary, Glasgow, Scotland, UK
    • Corresponding Author InformationAddress reprint requests to Colin C. Geddes, FRCP(Glasgow), The Renal Unit, Western Infirmary, Glasgow, Scotland G11 6NT UK

Received 17 September 2003 ,Revised 12 January 2004 ,Accepted 12 January 2004.

References 

  1. Allen RP, Hening W, Montplaisir J, et al.  Restless legs syndrome (RLS), a common disorder rarely diagnosed in Europe or USA (The REST (RLS Epidemiology, Symptoms and Treatment) study in primary care). Mov Disord. 2002;17(suppl 5):S240A; (abstr)
  2. Cooke B. In: The London Practice of Physick. Boston, MA: Milford House; 1973;p. 104
  3. Winkelman JW. Restless legs syndrome. Arch Neurol. 1999;56:1526–1527
  4. Chekhov A. The wedding proposal. In:  Garnett C editors. The Russian. London, UK: Chatto & Windus; 1965;p. 257
  5. Ekbom K. Restless legs syndrome. Acta Med Scand. 1945;158(suppl 1):S4–S122
  6. Ondo W, Jankovic J. Restless legs syndrome. In:  Appel S editors. Current Neurology. The Netherlands, IOS: Amsterdam; 1997;p. 207–235
  7. Allen RP, Earley CJ. Restless legs syndrome (A review of clinical and pathophysiologic features). J Clin Neurophysiol. 2001;18:128–147
  8. Ondo W, Vuong K, Wang Q. Restless legs syndrome in monozygotic twins (Clinical correlates). Neurology. 2000;55:1404–1406
  9. Desautels A, Turecki G, Montplaisir J, et al.  Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet. 2001;69:1266–1270
  10. Bonati M, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain. 2003;126:1485–1492
  11. Desautels A, Turecki G, Montplaisir J, et al.  Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology. 2002;59:215–219
  12. Filho G, Gorini C, Purysko A, Silva H, Elias I. Restless legs syndrome in patients on chronic hemodialysis in a Brazilian city (Frequency, biochemical findings and comorbidities). Arq Neuropsiquiatr. 2003;61:723–727
  13. Miranda M, Araya F, Castillo J, Duran C, Gonzalez F, Aris L. Restless legs syndrome (A clinical study in adult general population and in uraemic patients). Rev Med Chil. 2001;129:179–186
  14. Huiqi Q, Shan L, Mingcai Q. Restless legs syndrome (RLS) in uraemic patients is related to the frequency of haemodialysis sessions. Nephron. 2000;86:540
  15. Hui D, Wong T, Ko F, et al.  Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 2000;36:783–788
  16. Roger S, Harris D, Stewart J. Possible relation between restless legs and anaemia in renal dialysis patients. Lancet. 1991;337:1551
  17. Walker S, Fine A, Kryger M. Sleep complaints are common in a dialysis unit. Am J Kidney Dis. 1995;26:751–758
  18. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis. 1996;28:372–378
  19. Siddiqui S, Mak M, Kavanagh D, Geddes CC. Restless legs syndrome in haemodialysis patients. 2003; Presented at the Scottish Renal Association, May 9–10, Dumfries, Scotland
  20. Collad-Seidel V, Kohnen R, Samtleben W, Hillebrand G, Oertel W, Trenkwalder C. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis. 1998;31:324–328
  21. Sabbatini M, Minale B, Crispo A, et al.  Restless legs syndrome in maintenance haemodialysis patients. Nephrol Dial Transplant. 2002;17:852–856
  22. Bhowmik D, Bhatia M, Gupta S, Agarwal S, Tiwari S, Dash S. Restless legs syndrome in haemodialysis patients in India (A case controlled study). Sleep Med. 2003;4:143–146
  23. Takaki J, Nishi T, Nangaku M, et al.  Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis. 2003;41:833–839
  24. Walters AS. Towards a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord. 1995;10:634–642
  25. Cirignotta F, Mondini S, Santoro A, Ferrari G, Gerardi R, Buzzi G. Reliability of a questionnaire screening restless legs syndrome in patients on chronic dialysis. Am J Kidney Dis. 2002;40:302–306
  26. Kutner N, Bliwise D. Restless legs complaint in African-American and Caucasian hemodialysis patients. Sleep Med. 2002;3:497–500
  27. De Vecchi A, Finazzi S, Padalino R, et al.  Sleep disorders in peritoneal and haemodialysis patients as assessed by a self administered questionnaire. Int J Artif Organs. 2000;23:237–242
  28. Winkelman JW, Chertow GM, Lagos L, et al.  Restless legs syndrome is associated with reduced long term survival in patients with end stage renal disease. 1996; Presented at the 10th Annual Associated Professional Sleep Studies Meeting, June, Washington, DC
  29. Pressman M, Benz RL, Paterson D. Periodic leg movements in sleep index predicts mortality in end stage renal disease patients. Sleep Res. 1995;24:416A; (abstr)
  30. Wetter T, Stiasny K, Kohnen R, Oertel W, Trenkwalder C. Polysomnographic sleep measures in patients with uraemic and idiopathic restless legs syndrome. Mov Disord. 1998;13:820–824
  31. Winkelmann J, Wetter T, Collad-Seidel V, et al.  Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep. 2000;23:597–602
  32. Allen RP, Picchietti D, Hening W, et al.  Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med. 2003;101–119
  33. Montplaisir J, Boucher S, Poirer G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnography and genetic characteristics of restless legs syndrome (A study of 133 patients diagnosed with new standard criteria). Mov Disord. 1997;12:61–65
  34. Akpinar S. Treatment of restless legs with levodopa plus benserazide. Arch Neurol. 1982;39:739
  35. Montplaisir J, Godbout R, Poirer G, Bedard M. Restless legs syndrome and periodic movements in sleep; physiology and treatment with L-dopa. Clin Neuropharmacol. 1986;9:456–463
  36. Winkelmann J, Schadrack J, Wetter T, Zieglgansberger W, Trenkwalder C. Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Med. 2001;2:57–61
  37. Staedt J, Stoppe G, Kogler A, et al.  Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatr Clin Neurosci. 1995;245:8–10
  38. Michaud M, Soucy J, Chabli A, et al.  SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic limb movements in sleep. J Neurol. 2002;249:164–170
  39. Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome. Neurology. 1999;52:932–937
  40. Tribl G, Asenbaum S, Klosch G, et al.  Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome. Neurology. 2002;59:649–650
  41. Eisensehr I, Wetter T, Linke R, et al.  Normal IPT and IBZM SPECT in drug naive and levodopa- treated idiopathic restless legs syndrome. Neurology. 2001;57:1307–1309
  42. Trenkwalder C, Walters AS, Hening W, et al.  Positron emission tomographic studies in restless legs syndrome. Mov Disord. 1999;14:141–145
  43. Turjanski N, Lees AJ, Brooks DJ. Dopaminergic dysfunction in patients with restless legs ((18F) Dopa and (1C) raclopride PET studies). Neurology. 1998;50(suppl 4):S391A; (abstr)
  44. Ruottinen H, Partinen M, Hublin C, et al.  An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology. 2000;54:502–504
  45. Briellmann R, Rosler K, Hess C. Blink reflex excitability is abnormal in patients with periodic leg movements in sleep. Mov Disord. 1996;11:710–714
  46. Wechsler L, Stakes J, Shahani B, Busis N. Periodic leg movements of sleep (nocturnal myoclonus) (An electrophysiological study). Ann Neurol. 1986;19:168–173
  47. Bucher S, Seelos K, Oertel W, et al.  Cerebral generators involved in the pathogenesis of restless legs syndrome. Ann Neurol. 1997;41:639–645
  48. Bucher S, Trenkwalder C, Oertel W. Reflex studies and the MRI in the restless legs syndrome. Acta Med Scand. 1996;94:145–150
  49. Chokroverty S. Editor’s corner (Restless legs syndrome, a common disease uncommonly diagnosed). Sleep Med. 2003;4:91–93
  50. Tergau F, Wischer S, Paulus W. Motor system excitability in patients with restless legs syndrome. Neurology. 1999;52:1060–1063
  51. Entezari-Taher M, Singleton J, Jones C, et al.  Changes in excitability of motor cortical circuitry in primary restless legs syndrome. Neurology. 1999;53:1201–1205
  52. Bara-Jimenez W, Aksu M, Graham B, et al.  Periodic limb movements in sleep (State-dependent excitability of the spinal flexor reflex). Neurology. 2000;54:1609–1616
  53. Aksu M, Bara-Jimenez W. State dependent excitability changes of spinal flexor reflex in patients with restless legs syndrome secondary to chronic renal failure. Sleep Med. 2002;3:427–430
  54. Fry J. Restless legs syndrome and periodic leg movements in sleep exacerbated or caused by minimal iron deficiency. Neurology. 1986;36(suppl 1):S276A; (abstr)
  55. Matthews WB. Iron deficiency and restless legs. BMJ. 1976;1:898
  56. Benz RL, Pressman MR, Hovick ET, Peterson DD. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study). Am J Kidney Dis. 1999;34:1089–1095
  57. O’Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23:200–203
  58. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep. 1998;21:371–377
  59. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54:1698–1700
  60. Allen R, Barker P, Wehr F, Song H, Earley C. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56:263–265
  61. Connor JR, Boyer P, Menzies S, et al.  Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61:304–309
  62. Richert A, Osuna E, Sateia M, Remillard B. A survey of sleep and restless legs in haemodialysis, peritoneal dialysis and renal transplant populations. Sleep. 1998;21(suppl 1):S91A; (abstr)
  63. Garvey M, Tollefson G. Occurrence of myoclonus in patients treated with tricyclic antidepressants. Arch Gen Psychiatry. 1987;44:269–272
  64. Bakshi R. Fluoxetine and restless legs syndrome. J Neurol Sci. 1996;142:151–152
  65. Terao T, Terao M, Yoshimura R, Abe K. Restless legs syndrome induced by lithium. Biol Psychiatry. 1991;30:1167–1170
  66. Dimmit S, Riley G. Selective serotonin receptor uptake inhibitors can reduce restless legs symptoms. Arch Intern Med. 2000;160:712–715
  67. Kerr PG, van Bakel C, Dawborn JK. Assessment of the symptomatic benefit of cool dialysate. Nephron. 1989;52:166–169
  68. Davis B, Rajput A, Rajput M, Aul E, Eichhorn G. A randomised double blind placebo controlled trial of iron restless legs syndrome. Eur J Neurosci. 1998;43:70–75
  69. Norlander N. Restless legs. Br J Phys Med. 1954;17:160–162
  70. Akpinar S. Restless legs syndrome treatment with dopaminergic drugs. Clin Neuropharmacol. 1987;10:69–79
  71. Von Scheele C. Levodopa in restless legs. Lancet. 1986;2:426–427
  72. Brodeur C, Montplaisir J, Godbout R, Marinier R. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa (A double blind controlled trial). Neurology. 1988;38:1845–1848
  73. Trenkwalder C, Stiasny K, Pollmacher T, et al.  L-Dopa therapy of uraemic and idiopathic restless legs syndrome (Double blind, crossover trial). Sleep. 1995;18:681–688
  74. Sandyk R, Bernick C, Lee S, Stern L, Iacono R, Bamford C. L-Dopa in uraemic patients with the restless legs syndrome. Int J Neurosci. 1987;35:233–235
  75. Walker S, Fine A, Kryger M. L-Dopa/carbidopa for nocturnal movement disorders in uraemia. Sleep. 1996;19:214–218
  76. Earley CJ, Allen RP. Pergolide and carbidopa/levodpa treatment of restless legs syndrome and periodic leg movements in a consecutive series of patients. Sleep. 1996;19:801–810
  77. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep. 1996;19:205–213
  78. Wetter T, Stiasny K, Winkelman JW, et al.  A randomised controlled study of pergolide in patients with restless legs syndrome. Neurology. 1999;52:944–950
  79. Silber M, Shepard J, Wisbey J. Pergolide in the management of restless legs syndrome (An extended study). Sleep. 1997;20:878–882
  80. Earley CJ, Yaffee J, Allen RP. Randomised, double-blind controlled trial of pergolide in restless legs syndrome. Neurology. 1998;51:1599–1602
  81. Trenkwalder C, Brandenburg U, Hundemer H, et al.  A randomised long-term placebo controlled multicenter trial of pergolide in the treatment of restless legs syndrome with central evaluation of polysomnographic data. Neurology. 2001;56(suppl 3):S5A; (abstr)
  82. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole (A double blind randomised controlled trial). Neurology. 1999;52:938–943
  83. Ondo W. Ropinirole for restless legs syndrome. Mov Disord. 1999;14:138–140
  84. Pieta J, Millar T, Zacharias J, Fine A, Kryger M. Effect of pergolide on restless legs and leg movements in sleep in uraemic patients. Sleep. 1998;21:617–622
  85. Staedt J, Wabmuth F, Ziemann U, Hajak G, Ruther E, Stoppe G. Pergolide: Treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double blind randomized crossover trial of pergolide versus L-dopa. J Neural Transm. 1997;104:461–468
  86. Staedt J, Hunerjager H, Ruther E, Stoppe G. Pergolide: Treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS): Long term follow up on pergolide. J Neural Transm. 1998;105:265–268
  87. Stiasny K, Wetter T, Winkelman JW, et al.  Long term effects of pergolide in the treatment of restless legs syndrome. Neurology. 2001;56:1399–1402
  88. Hening W, Allen RP, Earley CJ, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder (An American Academy of Sleep Medicine review). Sleep. 1999;22:970–999
  89. Walters AS, Wagner M, Hening W, et al.  Successful treatment of the idiopathic restless legs syndrome in a randomised double blind trial of oxycodone versus placebo. Sleep. 1993;16:327–332
  90. Boghen D, Lamothe L, Elie R, Godbout R, Montplaisir J. The treatment of the restless legs syndrome with clonazepam (A prospective controlled study). Can J Neurol Sci. 1986;13:245–247
  91. Montagna P, Sassoli de Bianchi L, Zucconi M, Cirignotta F, Lugaresi E. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand. 1984;69:428–430
  92. Schenck CH, Mahowald MW. Long term, benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med. 1996;100:333–337
  93. Read DJ, Feest TG, Nassim MA. Clonazepam (Effective treatment for restless legs syndrome in uraemia). BMJ. 1981;283:885–886
  94. Telstad W, Sorensen O, Larsen S, Lillevold P, Stensrud P, Nyberg-Hansen R. Treatment of restless legs syndrome with carbemazepine (A double blind study). BMJ. 1984;288:444–446
  95. Adler C. Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol. 1997;20:148–151
  96. Mellick GA, Mellick LB. Management of restless legs syndrome with gabapentin. Sleep. 1996;19:224–226
  97. Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin. A double blind, cross over study. Neurology. 2002;59:1573–1579
  98. Thorp M, Morris C, Bagby S. A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am J Kidney Dis. 2001;38:104–108
  99. Wagner M, Walters AS, Coleman R, Hening W, Grasing K, Chokroverty S. Randomised double blind placebo controlled study of clonidine in restless legs syndrome. Sleep. 1996;19:52–58
  100. Ausserwinkler M, Schimdt P. Successful clonidine treatment of restless legs syndrome in chronic kidney insufficiency. Schweiz Med Wochenschr. 1989;119:184–186
  101. Evidente V, Adler C, Caviness J, Hentz J, Gwinn-Hardy K. Amantadine is beneficial in restless legs syndrome. Mov Disord. 2000;15:324–327
  102. Guilleminault C, Flagg W. Effect of baclofen on sleep related periodic movements. Ann Neurol. 1984;15:234–239
  103. Kapur N, Friedman R. Oral ketamine (A promising treatment for restless legs syndrome). Anesth Analg. 2002;94:1558–1559
  104. Yasuda T, Nishimura A, Katsuki Y, Tsuji Y. Restless legs syndrome treated successfully by kidney transplantation—A case report. Clin Transpl. 1986;1986:138
  105. Winkelmann JW, Stautner A, Samtleben W, Trenkwalder C. Long term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord. 2002;17:1072–1076

PII: S0272-6386(04)00128-3

doi: 10.1053/j.ajkd.2004.01.007

American Journal of Kidney Diseases
Volume 43, Issue 5 , Pages 763-771 , May 2004

Article Tools